Dr. Mojtaba Akhtari, M.D.
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Years since graduation
- 33
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 204
Licensed in Illinois since 2006, according to the Illinois Department of Financial and Professional Regulation. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
NE license 25688 · CA license A129758 (first issued 2014; current) -
Internal Medicine Physician
GA license 60234 · IL license 036116898 (first issued 2006; not renewed)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Loma Linda University Medical Center Loma Linda, CA
Medical groups
- Faculty Physicians and Surgeons of Llusm (1,315 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 204
- Services billed
- 814
- Patients’ average age
- 70
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 400 | 118 |
| Established patient office or other outpatient visit, 10-19 minutes | 119 | 59 |
| Established patient office or other outpatient visit, 30-39 minutes | 93 | 51 |
| New patient office or other outpatient visit, 30-44 minutes | 17 | 17 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Acyclovir Other prescribers in Omaha, NE | 182 |
| Allopurinol Other prescribers in Omaha, NE | 112 |
| Pomalyst (pomalidomide) | 99 |
| Jakafi (ruxolitinib phosphate) | 70 |
| Sulfamethoxazole-Trimethoprim (sulfamethoxazole/trimethoprim) Other prescribers in Omaha, NE | 58 |
| Dexamethasone Other prescribers in Omaha, NE | 56 |
| Ondansetron Hcl Other prescribers in Omaha, NE | 55 |
| Imbruvica (ibrutinib) | 45 |
| Ondansetron Odt (ondansetron) Other prescribers in Omaha, NE | 45 |
| Mirtazapine Other prescribers in Omaha, NE | 45 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 21 companies reported 267 payments worth $481,067 in total to this clinician.
| Incyte Corporation | $70,545 |
|---|---|
| Syndax Pharmaceuticals, Inc. | $58,171 |
| Karyopharm Therapeutics Inc. | $48,424 |
| E.r. Squibb & Sons, L.l.c. | $47,295 |
| AbbVie Inc. | $44,315 |
| Pfizer Inc. | $41,630 |
| Astellas Pharma US Inc | $37,129 |
| GlaxoSmithKline, LLC. | $34,778 |
| Compensation for services other than consulting (speaking, faculty) | $396,875 |
|---|---|
| Honoraria | $46,863 |
| Consulting Fee | $13,792 |
| Food and Beverage | $10,772 |
| Travel and Lodging | $6,786 |
| Speaking at a medical education program | $5,780 |
| Education | $199 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Genzyme Corporation Nov 25, 2025 | Compensation for services other than consulting (speaking, faculty) SARCLISA · Oncology | $7,064 |
| Genzyme Corporation Sep 25, 2025 | Compensation for services other than consulting (speaking, faculty) SARCLISA · Oncology | $7,064 |
| E.r. Squibb & Sons, L.l.c. Nov 24, 2025 | Compensation for services other than consulting (speaking, faculty) REBLOZYL · Hematology | $6,210 |
| E.r. Squibb & Sons, L.l.c. Dec 23, 2025 | Compensation for services other than consulting (speaking, faculty) ABECMA · Oncology | $6,210 |
| Karyopharm Therapeutics Inc. Jan 8, 2025 | Honoraria XPOVIO · Oncology | $5,705 |
| Karyopharm Therapeutics Inc. Feb 26, 2025 | Honoraria XPOVIO · Oncology | $5,705 |
| Karyopharm Therapeutics Inc. Apr 24, 2025 | Honoraria XPOVIO · Oncology | $5,705 |
| Syndax Pharmaceuticals, Inc. Apr 3, 2025 | Compensation for services other than consulting (speaking, faculty) REVUFORJ · HEMATOLOGY-ONCOLOGY | $5,600 |
| Incyte Corporation Jul 16, 2025 | Compensation for services other than consulting (speaking, faculty) Monjuvi · Oncology | $5,480 |
| E.r. Squibb & Sons, L.l.c. Aug 14, 2025 | Compensation for services other than consulting (speaking, faculty) REBLOZYL · Hematology | $5,175 |
All 149 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| E.r. Squibb & Sons, L.l.c. Dec 23, 2025 | Compensation for services other than consulting (speaking, faculty) ABECMA · Oncology | $6,210 |
| Pharmaessentia USA Corporation Dec 23, 2025 | Compensation for services other than consulting (speaking, faculty) BESREMI · Oncology | $1,340 |
| Incyte Corporation Dec 19, 2025 | Compensation for services other than consulting (speaking, faculty) Jakafi; Niktimvo · Hematology/Oncology | $2,740 |
| AbbVie Inc. Dec 18, 2025 | Compensation for services other than consulting (speaking, faculty) VENCLEXTA · ONCOLOGY | $4,200 |
| Syndax Pharmaceuticals, Inc. Dec 18, 2025 | Compensation for services other than consulting (speaking, faculty) REVUFORJ · HEMATOLOGY-ONCOLOGY | $1,200 |
| Karyopharm Therapeutics Inc. Dec 17, 2025 | Honoraria XPOVIO · Oncology | $4,075 |
| Secura Bio, Inc. Dec 15, 2025 | Compensation for services other than consulting (speaking, faculty) COPIKTRA · ORAL ONCOLOGIC | $3,960 |
| Pfizer Inc. Dec 10, 2025 | Compensation for services other than consulting (speaking, faculty) ELREXFIO · ONCOLOGY | $3,275 |
| Incyte Corporation Dec 8, 2025 | Compensation for services other than consulting (speaking, faculty) Monjuvi · Oncology | $2,740 |
| Syndax Pharmaceuticals, Inc. Dec 5, 2025 | Compensation for services other than consulting (speaking, faculty) REVUFORJ · HEMATOLOGY-ONCOLOGY | $4,400 |
| Karyopharm Therapeutics Inc. Dec 4, 2025 | Honoraria XPOVIO · Oncology | $4,075 |
| Incyte Corporation Dec 3, 2025 | Compensation for services other than consulting (speaking, faculty) Monjuvi · Oncology | $4,110 |
| Incyte Corporation Dec 3, 2025 | Compensation for services other than consulting (speaking, faculty) Monjuvi · Oncology | $4,110 |
| Astellas Pharma US Inc Dec 2, 2025 | Compensation for services other than consulting (speaking, faculty) Xospata · Oncology | $4,110 |
| E.r. Squibb & Sons, L.l.c. Nov 28, 2025 | Consulting Fee | $518 |
| E.r. Squibb & Sons, L.l.c. Nov 28, 2025 | Consulting Fee | $518 |
| E.r. Squibb & Sons, L.l.c. Nov 26, 2025 | Travel and Lodging ABECMA · Oncology · travel to Rancho Mirage, CA | $675 |
| Genzyme Corporation Nov 25, 2025 | Compensation for services other than consulting (speaking, faculty) SARCLISA · Oncology | $7,064 |
| Sobi, Inc Nov 25, 2025 | Compensation for services other than consulting (speaking, faculty) Vonjo · Hematology/Oncology | $5,088 |
| Syndax Pharmaceuticals, Inc. Nov 25, 2025 | Compensation for services other than consulting (speaking, faculty) REVUFORJ · HEMATOLOGY-ONCOLOGY | $2,000 |
| E.r. Squibb & Sons, L.l.c. Nov 24, 2025 | Compensation for services other than consulting (speaking, faculty) REBLOZYL · Hematology | $6,210 |
| Secura Bio, Inc. Nov 24, 2025 | Compensation for services other than consulting (speaking, faculty) COPIKTRA · ORAL ONCOLOGIC | $3,960 |
| AbbVie Inc. Nov 20, 2025 | Compensation for services other than consulting (speaking, faculty) VENCLEXTA · ONCOLOGY | $4,200 |
| AbbVie Inc. Nov 20, 2025 | Compensation for services other than consulting (speaking, faculty) EPKINLY · ONCOLOGY | $4,200 |
| Astellas Pharma US Inc Nov 19, 2025 | Compensation for services other than consulting (speaking, faculty) Xospata · Oncology | $685 |
| Syndax Pharmaceuticals, Inc. Nov 13, 2025 | Compensation for services other than consulting (speaking, faculty) REVUFORJ · HEMATOLOGY-ONCOLOGY | $3,600 |
| Syndax Pharmaceuticals, Inc. Nov 13, 2025 | Compensation for services other than consulting (speaking, faculty) REVUFORJ · HEMATOLOGY-ONCOLOGY | $2,000 |
| GlaxoSmithKline, LLC. Nov 11, 2025 | Compensation for services other than consulting (speaking, faculty) OJJAARA · ONCOLOGY | $2,850 |
| Incyte Corporation Nov 11, 2025 | Compensation for services other than consulting (speaking, faculty) Monjuvi · Oncology | $2,055 |
| Incyte Corporation Nov 11, 2025 | Compensation for services other than consulting (speaking, faculty) Monjuvi · Oncology | $2,055 |
| Pharmaessentia USA Corporation Nov 10, 2025 | Compensation for services other than consulting (speaking, faculty) BESREMI · Oncology | $3,350 |
| GlaxoSmithKline, LLC. Nov 5, 2025 | Compensation for services other than consulting (speaking, faculty) OJJAARA · ONCOLOGY | $3,800 |
| GlaxoSmithKline, LLC. Nov 5, 2025 | Compensation for services other than consulting (speaking, faculty) OJJAARA · ONCOLOGY | $475 |
| Sobi, Inc Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty) Vonjo · Hematology/Oncology | $5,088 |
| AbbVie Inc. Oct 29, 2025 | Compensation for services other than consulting (speaking, faculty) EPKINLY · ONCOLOGY | $4,200 |
| Pfizer Inc. Oct 29, 2025 | Consulting Fee ELREXFIO · ONCOLOGY | $2,025 |
| Genmab U.S., Inc. Oct 29, 2025 | Compensation for services other than consulting (speaking, faculty) Epkinly · Oncology | $600 |
| Astellas Pharma US Inc Oct 28, 2025 | Compensation for services other than consulting (speaking, faculty) Xospata · Oncology | $4,110 |
| GlaxoSmithKline, LLC. Oct 28, 2025 | Compensation for services other than consulting (speaking, faculty) OJJAARA · ONCOLOGY | $3,800 |
| E.r. Squibb & Sons, L.l.c. Oct 23, 2025 | Travel and Lodging REBLOZYL · Hematology · travel to Palm Desert, CA | $851 |
| Geron Corporation Oct 22, 2025 | Compensation for services other than consulting (speaking, faculty) RYTELO · MYELODYSPLASTIC SYNDROME | $4,800 |
| Pharmaessentia USA Corporation Oct 20, 2025 | Compensation for services other than consulting (speaking, faculty) BESREMI · Oncology | $3,350 |
| AbbVie Inc. Oct 16, 2025 | Travel and Lodging EPKINLY · ONCOLOGY · travel to PALM DESERT, CA · in-kind | $506 |
| Incyte Corporation Oct 9, 2025 | Compensation for services other than consulting (speaking, faculty) Jakafi; Niktimvo · Hematology/Oncology | $685 |
| Geron Corporation Oct 8, 2025 | Compensation for services other than consulting (speaking, faculty) RYTELO · MYELODYSPLASTIC SYNDROME | $4,000 |
| GlaxoSmithKline, LLC. Oct 6, 2025 | Compensation for services other than consulting (speaking, faculty) OJJAARA · ONCOLOGY | $3,800 |
| E.r. Squibb & Sons, L.l.c. Oct 1, 2025 | Compensation for services other than consulting (speaking, faculty) REBLOZYL · Hematology | $5,175 |
| Genzyme Corporation Sep 25, 2025 | Compensation for services other than consulting (speaking, faculty) SARCLISA · Oncology | $7,064 |
| Incyte Corporation Sep 24, 2025 | Compensation for services other than consulting (speaking, faculty) Monjuvi · Oncology | $4,110 |
| Karyopharm Therapeutics Inc. Sep 23, 2025 | Honoraria XPOVIO · Oncology | $4,075 |
| Pfizer Inc. Sep 23, 2025 | Compensation for services other than consulting (speaking, faculty) ELREXFIO · ONCOLOGY | $3,275 |
| Karyopharm Therapeutics Inc. Sep 22, 2025 | Honoraria XPOVIO · Oncology | $4,075 |
| Pharmaessentia USA Corporation Sep 22, 2025 | Compensation for services other than consulting (speaking, faculty) BESREMI · Oncology | $3,350 |
| AbbVie Inc. Sep 18, 2025 | Compensation for services other than consulting (speaking, faculty) EPKINLY · ONCOLOGY | $4,200 |
| E.r. Squibb & Sons, L.l.c. Sep 18, 2025 | Compensation for services other than consulting (speaking, faculty) REBLOZYL · Hematology | $4,140 |
| Incyte Corporation Sep 16, 2025 | Compensation for services other than consulting (speaking, faculty) Monjuvi · Oncology | $2,740 |
| AbbVie Inc. Sep 11, 2025 | Compensation for services other than consulting (speaking, faculty) EPKINLY · ONCOLOGY | $4,200 |
| E.r. Squibb & Sons, L.l.c. Sep 10, 2025 | Compensation for services other than consulting (speaking, faculty) ABECMA · Oncology | $5,175 |
| Astellas Pharma US Inc Sep 4, 2025 | Compensation for services other than consulting (speaking, faculty) Xospata · Oncology | $4,110 |
| Incyte Corporation Aug 27, 2025 | Compensation for services other than consulting (speaking, faculty) Monjuvi · Oncology | $4,110 |
| Pfizer Inc. Aug 27, 2025 | Travel and Lodging ELREXFIO · ONCOLOGY · travel to Palm Desert, CA · in-kind | $881 |
| Pfizer Inc. Aug 25, 2025 | Compensation for services other than consulting (speaking, faculty) ELREXFIO · ONCOLOGY | $4,250 |
| AbbVie Inc. Aug 25, 2025 | Compensation for services other than consulting (speaking, faculty) EPKINLY · ONCOLOGY | $4,200 |
| Servier Pharmaceuticals LLC Aug 21, 2025 | Speaking at a medical education program Tibsovo · Oncology | $5,100 |
| Incyte Corporation Aug 19, 2025 | Compensation for services other than consulting (speaking, faculty) Jakafi · Hematology/Oncology | $4,110 |
| AbbVie Inc. Aug 19, 2025 | Compensation for services other than consulting (speaking, faculty) VENCLEXTA · ONCOLOGY | $3,000 |
| Incyte Corporation Aug 19, 2025 | Compensation for services other than consulting (speaking, faculty) Niktimvo · Oncology | $2,740 |
| E.r. Squibb & Sons, L.l.c. Aug 14, 2025 | Compensation for services other than consulting (speaking, faculty) REBLOZYL · Hematology | $5,175 |
| Syndax Pharmaceuticals, Inc. Aug 14, 2025 | Compensation for services other than consulting (speaking, faculty) REVUFORJ · HEMATOLOGY-ONCOLOGY | $4,400 |
| Incyte Corporation Aug 12, 2025 | Compensation for services other than consulting (speaking, faculty) Monjuvi · Oncology | $4,110 |
| AbbVie Inc. Aug 8, 2025 | Compensation for services other than consulting (speaking, faculty) EPKINLY · ONCOLOGY | $3,000 |
| Astellas Pharma US Inc Aug 7, 2025 | Compensation for services other than consulting (speaking, faculty) Xospata · Oncology | $4,110 |
| AbbVie Inc. Aug 4, 2025 | Compensation for services other than consulting (speaking, faculty) VENCLEXTA · ONCOLOGY | $3,000 |
| Syndax Pharmaceuticals, Inc. Jul 31, 2025 | Compensation for services other than consulting (speaking, faculty) REVUFORJ · HEMATOLOGY-ONCOLOGY | $4,400 |
| Syndax Pharmaceuticals, Inc. Jul 31, 2025 | Travel and Lodging REVUFORJ · HEMATOLOGY-ONCOLOGY · travel to PALM DESERT, CA · in-kind | $1,432 |
| Incyte Corporation Jul 29, 2025 | Compensation for services other than consulting (speaking, faculty) Monjuvi · Oncology | $4,110 |
| Astellas Pharma US Inc Jul 24, 2025 | Compensation for services other than consulting (speaking, faculty) Xospata · Oncology | $4,110 |
| Incyte Corporation Jul 16, 2025 | Compensation for services other than consulting (speaking, faculty) Monjuvi · Oncology | $5,480 |
| Karyopharm Therapeutics Inc. Jul 16, 2025 | Honoraria XPOVIO · Oncology | $4,075 |
| Incyte Corporation Jul 10, 2025 | Travel and Lodging Monjuvi · Oncology · travel to San Jose, CA | $584 |
| Incyte Corporation Jul 10, 2025 | Travel and Lodging Monjuvi · Oncology · travel to San Jose, CA | $389 |
| Pfizer Inc. Jul 9, 2025 | Compensation for services other than consulting (speaking, faculty) ELREXFIO · ONCOLOGY | $4,250 |
| Incyte Corporation Jul 3, 2025 | Compensation for services other than consulting (speaking, faculty) Monjuvi · Oncology | $400 |
| GlaxoSmithKline, LLC. Jun 24, 2025 | Compensation for services other than consulting (speaking, faculty) OJJAARA · ONCOLOGY | $3,200 |
| E.r. Squibb & Sons, L.l.c. Jun 13, 2025 | Consulting Fee | $518 |
| Incyte Corporation Jun 12, 2025 | Compensation for services other than consulting (speaking, faculty) Jakafi · Hematology/Oncology | $2,055 |
| Incyte Corporation Jun 12, 2025 | Compensation for services other than consulting (speaking, faculty) Jakafi · Hematology/Oncology | $685 |
| Pharmaessentia USA Corporation Jun 11, 2025 | Compensation for services other than consulting (speaking, faculty) BESREMI · Oncology | $3,350 |
| Pfizer Inc. Jun 5, 2025 | Compensation for services other than consulting (speaking, faculty) ADCETRIS · ONCOLOGY | $4,250 |
| Sobi, Inc May 29, 2025 | Compensation for services other than consulting (speaking, faculty) Vonjo · Hematology/Oncology | $5,088 |
| Sobi, Inc May 22, 2025 | Compensation for services other than consulting (speaking, faculty) Vonjo · Hematology/Oncology | $4,625 |
| Astellas Pharma US Inc May 20, 2025 | Compensation for services other than consulting (speaking, faculty) Xospata · Oncology | $4,110 |
| Incyte Corporation May 20, 2025 | Compensation for services other than consulting (speaking, faculty) Jakafi · Hematology/Oncology | $2,055 |
| Seagen Inc. May 20, 2025 | Education in-kind | $99.99 |
| Servier Pharmaceuticals LLC May 16, 2025 | Speaking at a medical education program Tibsovo · Oncology | $680 |
| Sobi, Inc May 15, 2025 | Compensation for services other than consulting (speaking, faculty) Vonjo · Hematology/Oncology | $5,088 |
| Karyopharm Therapeutics Inc. May 15, 2025 | Honoraria XPOVIO · Oncology | $4,075 |
| E.r. Squibb & Sons, L.l.c. May 15, 2025 | Consulting Fee | $518 |
| Pfizer Inc. May 12, 2025 | Compensation for services other than consulting (speaking, faculty) ADCETRIS · ONCOLOGY | $4,250 |
| AbbVie Inc. May 12, 2025 | Compensation for services other than consulting (speaking, faculty) VENCLEXTA · ONCOLOGY | $4,200 |
| Astellas Pharma US Inc May 12, 2025 | Compensation for services other than consulting (speaking, faculty) Xospata · Oncology | $4,110 |
| Syndax Pharmaceuticals, Inc. May 9, 2025 | Compensation for services other than consulting (speaking, faculty) REVUFORJ · HEMATOLOGY-ONCOLOGY | $2,000 |
| Karyopharm Therapeutics Inc. May 8, 2025 | Honoraria XPOVIO · Oncology | $4,075 |
| Geron Corporation May 7, 2025 | Compensation for services other than consulting (speaking, faculty) RYTELO · MYELODYSPLASTIC SYNDROME | $4,000 |
| Incyte Corporation May 7, 2025 | Compensation for services other than consulting (speaking, faculty) Monjuvi · Oncology | $2,740 |
| Syndax Pharmaceuticals, Inc. May 6, 2025 | Compensation for services other than consulting (speaking, faculty) REVUFORJ · HEMATOLOGY-ONCOLOGY | $4,400 |
| Karyopharm Therapeutics Inc. May 6, 2025 | Honoraria XPOVIO · Oncology | $1,223 |
| Pfizer Inc. May 6, 2025 | Consulting Fee ADCETRIS · ONCOLOGY | $720 |
| E.r. Squibb & Sons, L.l.c. May 1, 2025 | Compensation for services other than consulting (speaking, faculty) REBLOZYL · Hematology | $4,140 |
| Astellas Pharma US Inc Apr 29, 2025 | Compensation for services other than consulting (speaking, faculty) Xospata · Oncology | $2,055 |
| Karyopharm Therapeutics Inc. Apr 24, 2025 | Honoraria XPOVIO · Oncology | $5,705 |
| Karyopharm Therapeutics Inc. Apr 24, 2025 | Travel and Lodging XPOVIO · Oncology · travel to Palm Desert, CA · in-kind | $812 |
| Incyte Corporation Apr 23, 2025 | Compensation for services other than consulting (speaking, faculty) Monjuvi · Oncology | $2,740 |
| GlaxoSmithKline, LLC. Apr 22, 2025 | Compensation for services other than consulting (speaking, faculty) OJJAARA · ONCOLOGY | $3,200 |
| Astellas Pharma US Inc Apr 13, 2025 | Compensation for services other than consulting (speaking, faculty) Xospata · Oncology | $343 |
| GlaxoSmithKline, LLC. Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) OJJAARA · ONCOLOGY | $3,200 |
| GlaxoSmithKline, LLC. Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) OJJAARA · ONCOLOGY | $1,600 |
| Incyte Corporation Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) Jakafi · Hematology/Oncology | $343 |
| Syndax Pharmaceuticals, Inc. Apr 3, 2025 | Compensation for services other than consulting (speaking, faculty) REVUFORJ · HEMATOLOGY-ONCOLOGY | $5,600 |
| Pharmaessentia USA Corporation Mar 31, 2025 | Compensation for services other than consulting (speaking, faculty) BESREMI · Oncology | $1,340 |
| GlaxoSmithKline, LLC. Mar 25, 2025 | Compensation for services other than consulting (speaking, faculty) OJJAARA · ONCOLOGY | $3,200 |
| GlaxoSmithKline, LLC. Mar 24, 2025 | Travel and Lodging OJJAARA · ONCOLOGY · travel to Bakersfield, CA · in-kind | $25.00 |
| Sobi, Inc Mar 21, 2025 | Compensation for services other than consulting (speaking, faculty) Vonjo · Hematology/Oncology | $4,625 |
| Pfizer Inc. Mar 20, 2025 | Consulting Fee ELREXFIO · ONCOLOGY | $5,125 |
| Syndax Pharmaceuticals, Inc. Mar 20, 2025 | Compensation for services other than consulting (speaking, faculty) REVUFORJ · HEMATOLOGY-ONCOLOGY | $4,400 |
| Pfizer Inc. Mar 20, 2025 | Compensation for services other than consulting (speaking, faculty) ELREXFIO · ONCOLOGY | $4,250 |
| Incyte Corporation Mar 20, 2025 | Compensation for services other than consulting (speaking, faculty) Niktimvo · Oncology | $685 |
| Syndax Pharmaceuticals, Inc. Mar 20, 2025 | Travel and Lodging REVUFORJ · HEMATOLOGY-ONCOLOGY · travel to PHOENIX, AZ · in-kind | $529 |
| Syndax Pharmaceuticals, Inc. Mar 20, 2025 | Travel and Lodging REVUFORJ · HEMATOLOGY-ONCOLOGY · travel to PHOENIX, AZ · in-kind | $101 |
| Syndax Pharmaceuticals, Inc. Mar 14, 2025 | Compensation for services other than consulting (speaking, faculty) REVUFORJ · HEMATOLOGY-ONCOLOGY | $4,400 |
| Astellas Pharma US Inc Mar 14, 2025 | Education in-kind | $99.00 |
| Pharmaessentia USA Corporation Mar 12, 2025 | Compensation for services other than consulting (speaking, faculty) BESREMI · Oncology | $1,675 |
| Astellas Pharma US Inc Mar 3, 2025 | Compensation for services other than consulting (speaking, faculty) Xospata · Oncology | $4,110 |
| Syndax Pharmaceuticals, Inc. Feb 27, 2025 | Compensation for services other than consulting (speaking, faculty) REVUFORJ · HEMATOLOGY-ONCOLOGY | $4,400 |
| Karyopharm Therapeutics Inc. Feb 26, 2025 | Honoraria XPOVIO · Oncology | $5,705 |
| GlaxoSmithKline, LLC. Feb 25, 2025 | Compensation for services other than consulting (speaking, faculty) OJJAARA · ONCOLOGY | $3,200 |
| Secura Bio, Inc. Feb 19, 2025 | Compensation for services other than consulting (speaking, faculty) COPIKTRA · ORAL ONCOLOGIC | $1,650 |
| Sobi, Inc Feb 13, 2025 | Consulting Fee Vonjo · Hematology/Oncology | $1,850 |
| Geron Corporation Feb 12, 2025 | Compensation for services other than consulting (speaking, faculty) RYTELO · MYELODYSPLASTIC SYNDROME | $4,000 |
| Incyte Corporation Feb 11, 2025 | Compensation for services other than consulting (speaking, faculty) Monjuvi · Oncology | $4,110 |
| Pfizer Inc. Feb 10, 2025 | Compensation for services other than consulting (speaking, faculty) ELREXFIO · ONCOLOGY | $4,250 |
| Syndax Pharmaceuticals, Inc. Feb 6, 2025 | Compensation for services other than consulting (speaking, faculty) REVUFORJ · HEMATOLOGY-ONCOLOGY | $3,600 |
| Syndax Pharmaceuticals, Inc. Feb 6, 2025 | Compensation for services other than consulting (speaking, faculty) REVUFORJ · HEMATOLOGY-ONCOLOGY | $2,000 |
| GlaxoSmithKline, LLC. Jan 30, 2025 | Compensation for services other than consulting (speaking, faculty) OJJAARA · ONCOLOGY | $1,600 |
| Incyte Corporation Jan 21, 2025 | Compensation for services other than consulting (speaking, faculty) Monjuvi · Oncology | $2,055 |
| E.r. Squibb & Sons, L.l.c. Jan 17, 2025 | Compensation for services other than consulting (speaking, faculty) REBLOZYL · Hematology | $3,811 |
| E.r. Squibb & Sons, L.l.c. Jan 14, 2025 | Compensation for services other than consulting (speaking, faculty) REBLOZYL · Hematology | $3,176 |
| Syndax Pharmaceuticals, Inc. Jan 9, 2025 | Consulting Fee REVUFORJ · HEMATOLOGY-ONCOLOGY | $2,000 |
| Karyopharm Therapeutics Inc. Jan 8, 2025 | Honoraria XPOVIO · Oncology | $5,705 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.